KFDA approved once-a-week dose of Enbrel

The KFDA approved once a week administering dose of Enbrel of Wyeth Korea Inc., a drug for the treatment of rheumatoid arthritis, 25mg of which previously approved for twice a week dose of 3 to 4 days interval.

Wyeth Korea said that the efficacy and tolerance of Enbrel once-a-week administration has been proved by a phase III and double blind study for 420 arthritic patients. The study comp...